CATALYST PHARMACEUTICA

Catalyst Pharmaceuticals Announces Publication of Santhera Pharmaceutical’s VISION-DMD Vamorolone (AGAMREE®) Study Results in the Peer-Reviewed Journal Neurology

21 фев 2024 09:00:00 Источник Nasdaq GlobeNewswire

Catalyst Pharmaceuticals to Report Fourth Quarter and Full-Year 2023 Financial Results on February 28, 2024

14 фев 2024 08:03:00 Источник Nasdaq GlobeNewswire

Catalyst Pharmaceuticals, Inc. Announces Closing of Public Offering

09 янв 2024 16:05:13 Источник Nasdaq GlobeNewswire

Catalyst Pharmaceuticals, Inc. Announces Pricing of Public Offering of Common Stock

05 янв 2024 08:02:06 Источник Nasdaq GlobeNewswire

Catalyst Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock

04 янв 2024 16:49:58 Источник Nasdaq GlobeNewswire

Catalyst Pharmaceuticals Announces FIRDAPSE® New Drug Application Submitted in Japan by Partner DyDo Pharma

18 дек 2023 06:30:03 Источник Nasdaq GlobeNewswire

Catalyst Pharmaceuticals Receives Prestigious Ranking on Forbes 2024 List of America's Most Successful Small-Cap Companies

05 дек 2023 08:03:00 Источник Nasdaq GlobeNewswire

Catalyst Pharmaceuticals Announces Appointment of Michael W. Kalb as Chief Financial Officer and Other Executive Promotions

04 дек 2023 08:03:00 Источник Nasdaq GlobeNewswire

Catalyst Pharmaceuticals To Participate in Piper Sandler 35th Annual Healthcare Conference

16 ноя 2023 08:05:00 Источник Nasdaq GlobeNewswire

Catalyst Pharmaceuticals Reports Strong Third Quarter 2023 Financial Results and Corporate Update

08 ноя 2023 16:11:02 Источник Nasdaq GlobeNewswire

Catalyst Pharmaceuticals Receives Two New U.S. Patent Allowances For FIRDAPSE®

02 ноя 2023 10:37:31 Источник Nasdaq GlobeNewswire

Catalyst Pharmaceuticals Partners with Sofie's Journey to Bring Focus on Epilepsy at the 11th Annual Epilepsy Awareness and Education Expo

30 окт 2023 08:03:00 Источник Nasdaq GlobeNewswire

Catalyst Pharmaceuticals Reports FDA Approval of AGAMREE® (vamorolone) for Duchenne Muscular Dystrophy Granted to Santhera Pharmaceuticals

26 окт 2023 15:19:11 Источник Nasdaq GlobeNewswire

Catalyst Pharmaceuticals to Report Third Quarter 2023 Financial Results on November 8, 2023

23 окт 2023 08:03:00 Источник Nasdaq GlobeNewswire

Catalyst Pharmaceuticals Appoints Richard J. Daly as Chief Executive Officer

19 окт 2023 08:03:00 Источник Nasdaq GlobeNewswire

Patrick J. McEnany, Chairman and CEO of Catalyst Pharmaceuticals, Receives Prestigious 2023 Lifetime Achievement Award from BioFlorida

16 окт 2023 08:03:00 Источник Nasdaq GlobeNewswire

Catalyst Pharmaceuticals Announces FDA Acceptance of the Supplemental New Drug Application for FIRDAPSE®

13 окт 2023 08:03:00 Источник Nasdaq GlobeNewswire

Catalyst Pharmaceuticals to Participate at the 2023 Cantor Global Healthcare Conference

18 сен 2023 08:03:00 Источник Nasdaq GlobeNewswire

Catalyst Pharmaceuticals Announces Abstract on Lambert Eaton Myasthenic Syndrome (LEMS) to be Presented at the Upcoming IASLC 2023 World Conference of Lung Cancer

16 авг 2023 10:56:47 Источник Nasdaq GlobeNewswire

Catalyst Pharmaceuticals Announces Multiple Abstracts on FYCOMPA® (Perampanel) from Eisai Co, Ltd., to be Presented at the 35th International Epilepsy Congress

14 авг 2023 08:05:10 Источник Nasdaq GlobeNewswire